OxRML/AgentSLR huggingface dataset:
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 38
Unit: Percentage (%)
CFR/IFR numerator: 20
CFR/IFR denominator: 52
CFR/IFR method: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 21
Maximum age: 84
Sample size: 52
Country: Taiwan,  China
Location: Kaouhsiung
Study period: 26 Apr 04 2003 to 25 May 05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Age;Other
Risk factor outcome: Death
Risk factor significance: Significant
Risk factor adjustment: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 21
Maximum age: 84
Sample size: 52
Country: Taiwan,  China
Location: Kaouhsiung
Study period: 26 Apr 04 2003 to 25 May 05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Sex
Risk factor outcome: Death
Risk factor significance: Not significant
Risk factor adjustment: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 21
Maximum age: 84
Sample size: 52
Country: Taiwan,  China
Location: Kaouhsiung
Study period: 26 Apr 04 2003 to 25 May 05 2003
Pathogen: SARS-CoV
Parameter class: Seroprevalence
Parameter type: Seroprevalence - IFA
Parameter value: 0.8
Unit: Percentage (%)
Uncertainty type: 95% CI
Uncertainty lower value: 0.2
Uncertainty upper value: 3
Combined uncertainty: 0.2 - 3 (95% CI)
CFR/IFR numerator: 2
CFR/IFR denominator: 238
CFR/IFR method: Unspecified
Epidemic phase: Post outbreak
Population group: Healthcare workers
Sample type: Other
Sample size: 238
Country: Taiwan,  China
Location: Taipei
Study period: 15 Jul 07 2003 to 10 Aug 08 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Occupation
Risk factor outcome: Infection
Risk factor occupation: Healthcare
Risk factor significance: Unspecified
Risk factor adjustment: Unspecified
Population group: Healthcare workers
Sample type: Trade / business based
Sample size: 321
Country: Taiwan,  China
Location: Taipei
Study period: 18 Mar 03 2003 to 19 Jun 06 2003
Pathogen: SARS-CoV
Parameter class: Attack rate
Parameter type: Attack rate
Parameter value: 1.2
Unit: Percentage (%)
Lower bound: 0
Upper bound: 4.38
Bounds: 0 - 4.38
Disaggregated by: Occupation, Region, Time
Population group: Healthcare workers
Sample type: Hospital based
Sex: Unspecified
Sample size: 339
Country: Hong Kong SAR,  China
Study period: 4 Mar 03 2003 to 31 May 05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Risk factor: Other
Risk factor outcome: Infection
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: General population
Sample type: Population based
Sex: Both
Sample size: 330
Country: Hong Kong SAR,  China
Study period: 4 Apr 04 2003 to 10 Jun 06 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Risk factor: Close contact;Other
Risk factor outcome: Infection
Risk factor significance: Not significant
Risk factor adjustment: Not adjusted
Population group: General population
Sample type: Population based
Sex: Both
Sample size: 330
Country: Hong Kong SAR,  China
Study period: 4 Apr 04 2003 to 10 Jun 06 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Risk factor: Other
Risk factor outcome: Infection
Risk factor occupation: Other
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: General population
Sample type: Population based
Sex: Both
Sample size: 330
Country: Hong Kong SAR,  China
Study period: 4 Apr 04 2003 to 10 Jun 06 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Risk factor: Other
Risk factor outcome: Infection
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: Healthcare workers
Sample type: Hospital based
Sex: Both
Minimum age: 20
Sample size: 37174
Country: Hong Kong SAR,  China
Study period: 17 Apr 04 2003 to 17 Aug 08 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Risk factor: Age;Close contact;Other
Risk factor outcome: Infection
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: Household contacts of survivors
Sample type: Population based
Sex: Both
Minimum age: 18
Sample size: 2139
Country: Hong Kong SAR,  China
Study period: 4 Apr 04 2003 to 10 Jun 06 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Risk factor: Other;Sex
Risk factor outcome: Infection
Risk factor significance: Not significant
Risk factor adjustment: Not adjusted
Population group: Household contacts of survivors
Sample type: Population based
Sex: Both
Minimum age: 18
Sample size: 2139
Country: Hong Kong SAR,  China
Study period: 4 Apr 04 2003 to 10 Jun 06 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Risk factor: Close contact;Other
Risk factor outcome: Infection
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: Household contacts of survivors
Sample type: Population based
Sex: Both
Minimum age: 18
Sample size: 2139
Country: Hong Kong SAR,  China
Study period: 4 Apr 04 2003 to 10 Jun 06 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Risk factor: Age;Other;Sex
Risk factor outcome: Infection
Risk factor significance: Not significant
Risk factor adjustment: Adjusted
Population group: Household contacts of survivors
Sample type: Population based
Sex: Both
Minimum age: 18
Sample size: 2139
Country: Hong Kong SAR,  China
Study period: 4 Apr 04 2003 to 10 Jun 06 2003
Pathogen: SARS-CoV
Parameter class: Other transmission parameters
Parameter type: Secondary attack rate
Parameter value: 14.9
Unit: Percentage (%)
Value type: Unspecified
Uncertainty type: 95% CI
Uncertainty lower value: 12.6
Uncertainty upper value: 17.4
Combined uncertainty: 12.6 - 17.4 (95% CI)
Epidemic phase: Mid outbreak
Disaggregated by: Other, Time
Population group: General population
Sample type: Household based
Sex: Both
Minimum age: 18
Sample size: 881
Country: Hong Kong SAR,  China
Study period: 4 Apr 04 2003 to 10 Jun 06 2003
Pathogen: SARS-CoV
Parameter class: Other transmission parameters
Parameter type: Secondary attack rate
Parameter value: 8
Unit: Percentage (%)
Value type: Unspecified
Uncertainty lower value: 7
Uncertainty upper value: 9.2
Combined uncertainty: 7 - 9.2 ()
Epidemic phase: Mid outbreak
Disaggregated by: Other, Time
Population group: Household contacts of survivors
Sample type: Population based
Sex: Both
Minimum age: 18
Sample size: 2139
Country: Hong Kong SAR,  China
Study period: 4 Apr 04 2003 to 10 Jun 06 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Risk factor: Close contact;Other
Risk factor outcome: Infection
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: Healthcare workers
Sample type: Hospital based
Sex: Unspecified
Sample size: 216
Country: Hong Kong SAR,  China
Location: New Territories East
Study period: 28 Mar 03 2003 to 25 May 05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Risk factor: Close contact;Other
Risk factor outcome: Infection
Risk factor significance: Not significant
Risk factor adjustment: Not adjusted
Population group: Healthcare workers
Sample type: Hospital based
Sex: Unspecified
Sample size: 216
Country: Hong Kong SAR,  China
Location: New Territories East
Study period: 28 Mar 03 2003 to 25 May 05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Risk factor: Other
Risk factor outcome: Infection
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: Healthcare workers
Sample type: Hospital based
Sex: Unspecified
Sample size: 216
Country: Hong Kong SAR,  China
Location: New Territories East
Study period: 28 Mar 03 2003 to 25 May 05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Risk factor: Other
Risk factor outcome: Infection
Risk factor significance: Not significant
Risk factor adjustment: Adjusted
Population group: Healthcare workers
Sample type: Hospital based
Sex: Unspecified
Sample size: 216
Country: Hong Kong SAR,  China
Location: New Territories East
Study period: 28 Mar 03 2003 to 25 May 05 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 17.2
Unit: Percentage (%)
Value type: Mean
Uncertainty type: 95% CI
Uncertainty lower value: 15.4
Uncertainty upper value: 19
Combined uncertainty: 15.4 - 19 (95% CI)
CFR/IFR numerator: 302
CFR/IFR denominator: 1755
CFR/IFR method: Naive
Epidemic phase: Post outbreak
Disaggregated by: Age, Occupation, Other, Sex
Population group: General population
Sample type: Population based
Sex: Both
Sample size: 1755
Country: Hong Kong SAR,  China
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 3.3
Unit: Percentage (%)
Value type: Mean
Uncertainty type: 95% CI
Uncertainty lower value: 2.1
Uncertainty upper value: 4.4
Combined uncertainty: 2.1 - 4.4 (95% CI)
CFR/IFR numerator: 30
CFR/IFR denominator: 917
CFR/IFR method: Naive
Epidemic phase: Post outbreak
Disaggregated by: Age, Occupation, Other, Sex
Population group: General population
Sample type: Population based
Sex: Both
Sample size: 917
Country: China
Location: Beijing
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 27.6
Unit: Percentage (%)
Value type: Mean
Uncertainty type: 95% CI
Uncertainty lower value: 24.2
Uncertainty upper value: 31
Combined uncertainty: 24.2 - 31 (95% CI)
CFR/IFR numerator: 180
CFR/IFR denominator: 664
CFR/IFR method: Naive
Epidemic phase: Post outbreak
Disaggregated by: Age, Occupation, Other, Sex
Population group: General population
Sample type: Population based
Sex: Both
Sample size: 664
Country: Taiwan,  China
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - incubation period
Parameter value: 4.4
Unit: Days
Value type: Mean
Uncertainty single value: 4.6 (Standard deviation (Sd) [Sample])
Combined uncertainty: 4.6 (Standard deviation (Sd) [Sample])
Distribution type: Normal-Log
Epidemic phase: Post outbreak
Population group: General population
Sample type: Population based
Sex: Unspecified
Sample size: 168
Country: Hong Kong SAR,  China
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - incubation period
Parameter value: 5.7
Unit: Days
Value type: Mean
Uncertainty single value: 9.7 (Standard deviation (Sd) [Sample])
Combined uncertainty: 9.7 (Standard deviation (Sd) [Sample])
Distribution type: Normal-Log
Epidemic phase: Post outbreak
Population group: General population
Sample type: Population based
Sex: Unspecified
Sample size: 97
Country: China
Location: Beijing
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - incubation period
Parameter value: 6.9
Unit: Days
Value type: Mean
Uncertainty single value: 6.1 (Standard deviation (Sd) [Sample])
Combined uncertainty: 6.1 (Standard deviation (Sd) [Sample])
Distribution type: Normal-Log
Epidemic phase: Post outbreak
Population group: General population
Sample type: Population based
Sex: Unspecified
Sample size: 210
Country: Taiwan,  China
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Post outbreak
Risk factor: Age;Cormobidity;Occupation;Other
Risk factor outcome: Death
Risk factor occupation: Healthcare
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: General population
Sample type: Population based
Sex: Both
Sample size: 3336
Country: China, Hong Kong SAR,  China, Taiwan,  China
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Unit: Percentage (%)
Value type: Mean
Lower bound: 15.4
Upper bound: 19.2
Bounds: 15.4 - 19.2
Epidemic phase: Post outbreak
Disaggregated by: Other
Population group: General population
Sample type: Population based
Sex: Both
Sample size: 1743
Country: Hong Kong SAR,  China
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Unit: Percentage (%)
Value type: Mean
Lower bound: 13.4
Upper bound: 18.7
Bounds: 13.4 - 18.7
Epidemic phase: Post outbreak
Disaggregated by: Other
Population group: General population
Sample type: Population based
Sex: Both
Sample size: 191
Country: Canada
Location: Toronto
Study period: 2 Mar 03 2003 to 21 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: End outbreak
Risk factor: Age;Cormobidity;Other
Risk factor outcome: Recovery
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: General population
Sample type: Hospital based
Sex: Both
Minimum age: 13
Maximum age: 74
Sample size: 88
Country: Hong Kong SAR,  China
Location: Pamela Youde Nethersole Eastern Hospital
Study period: 9 Mar 03 2003 to 28 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: End outbreak
Risk factor: Other;Sex
Risk factor outcome: Recovery
Risk factor significance: Not significant
Risk factor adjustment: Adjusted
Population group: General population
Sample type: Hospital based
Sex: Both
Minimum age: 13
Maximum age: 74
Sample size: 88
Country: Hong Kong SAR,  China
Location: Pamela Youde Nethersole Eastern Hospital
Study period: 9 Mar 03 2003 to 28 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Basic R0)
Unit: No units
Value type: Mean
Lower bound: 0.595
Upper bound: 176
Bounds: 0.595 - 176
Epidemic phase: Mid outbreak
Reproduction number method: Next generation matrix
Reproduction number pathway: Human-human
Disaggregated by: Method
Population group: Mixed groups
Sample type: Hospital based
Sex: Both
Sample size: 390
Country: Hong Kong SAR,  China
Location: Hospital P
Study period: 11 Mar 03 2003 to 31 Jul 07 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 4
Unit: Days
Value type: Mean
Uncertainty type: Other
Uncertainty lower value: 3.6
Uncertainty upper value: 4.6
Combined uncertainty: 3.6 - 4.6 (Other)
Epidemic phase: Mid outbreak
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 390
Country: Hong Kong SAR,  China
Location: Hospital P
Study period: 11 Mar 03 2003 to 31 Jul 07 2003
Other delay start: Admission to Care/Hospitalisation
Other delay end: Recovery/non-Infectiousness
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 6.4
Unit: Percentage (%)
Value type: Other
Lower bound: 1.7
Upper bound: 25.5
Bounds: 1.7 - 25.5
CFR/IFR numerator: 343
CFR/IFR denominator: 5327
CFR/IFR method: Naïve
Epidemic phase: Mid outbreak
Disaggregated by: Age, Occupation, Other, Region, Sex, Time
Population group: General population
Sample type: Population based
Sex: Both
Minimum age: 0
Maximum age: 93
Sample size: 5327
Country: China
Location: mainland China
Study period: 16 Nov 11 2002 to   2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Risk factor: Occupation;Other
Risk factor outcome: Death
Risk factor occupation: Other
Risk factor significance: Not significant
Risk factor adjustment: Not adjusted
Population group: General population
Sample type: Population based
Sex: Both
Minimum age: 0
Maximum age: 93
Sample size: 5327
Country: China
Location: Mainland China
Study period: 16 Nov 11 2002 to   2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Risk factor: Age;Occupation;Other;Sex
Risk factor outcome: Death
Risk factor occupation: Healthcare
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: General population
Sample type: Population based
Sex: Both
Minimum age: 0
Maximum age: 93
Sample size: 5327
Country: China
Location: Mainland China
Study period: 16 Nov 11 2002 to   2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Risk factor: Occupation;Sex
Risk factor outcome: Death
Risk factor occupation: Healthcare
Risk factor significance: Not significant
Risk factor adjustment: Adjusted
Population group: General population
Sample type: Population based
Sex: Both
Minimum age: 0
Maximum age: 93
Sample size: 5327
Country: China
Location: Mainland China
Study period: 16 Nov 11 2002 to   2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Risk factor: Age;Other
Risk factor outcome: Death
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: General population
Sample type: Population based
Sex: Both
Minimum age: 0
Maximum age: 93
Sample size: 5327
Country: China
Location: Mainland China
Study period: 16 Nov 11 2002 to   2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 7.3
Unit: Percentage (%)
Value type: Other
CFR/IFR numerator: 184
CFR/IFR denominator: 2522
CFR/IFR method: Naïve
Epidemic phase: Mid outbreak
Population group: General population
Sample type: Population based
Sex: Both
Sample size: 2522
Country: China
Location: Beijing
Study period: 16 Nov 11 2002 to   2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 12
Unit: Percentage (%)
Value type: Other
CFR/IFR numerator: 21
CFR/IFR denominator: 175
CFR/IFR method: Naïve
Epidemic phase: Mid outbreak
Population group: General population
Sample type: Population based
Sex: Both
Sample size: 175
Country: China
Location: Tianjin
Study period: 16 Nov 11 2002 to   2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 3.6
Unit: Percentage (%)
Value type: Other
CFR/IFR numerator: 54
CFR/IFR denominator: 1504
CFR/IFR method: Naïve
Epidemic phase: Mid outbreak
Population group: General population
Sample type: Population based
Sex: Both
Sample size: 1504
Country: China
Location: Guangdong
Study period: 16 Nov 11 2002 to   2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 5.4
Unit: Percentage (%)
Value type: Other
CFR/IFR numerator: 24
CFR/IFR denominator: 449
CFR/IFR method: Naïve
Epidemic phase: Mid outbreak
Population group: General population
Sample type: Population based
Sex: Both
Sample size: 449
Country: China
Location: Shanxi
Study period: 16 Nov 11 2002 to   2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 9.9
Unit: Percentage (%)
Value type: Other
CFR/IFR numerator: 28
CFR/IFR denominator: 282
CFR/IFR method: Naïve
Epidemic phase: Mid outbreak
Population group: General population
Sample type: Population based
Sex: Both
Sample size: 282
Country: China
Location: Inner Mongolia
Study period: 16 Nov 11 2002 to   2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Unit: No units
Value type: Other
Lower bound: 0.064
Upper bound: 0.1442
Bounds: 0.064 - 0.1442
CFR/IFR method: Adjusted
Epidemic phase: Mid outbreak
Disaggregated by: Method, Time
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 1583
Country: Hong Kong SAR,  China
Study period: 2 Apr 04 2003 to  May 05 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - symptom onset>admission to care
Parameter value: 4.8
Unit: Days
Value type: Mean
Uncertainty single value: 2.3 (Standard deviation (Sd) [Estimator])
Combined uncertainty: 2.3 (Standard deviation (Sd) [Estimator])
Epidemic phase: Mid outbreak
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 22
Maximum age: 82
Sample size: 29
Country: Taiwan,  China
Location: Shin Kong
Wu Ho-Su Memorial Hospital, Taipei
Study period: 28 Mar 03 2003 to 30 Jun 06 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 6.8
Unit: Days
Value type: Mean
Uncertainty single value: 2.9 (Standard deviation (Sd) [Sample])
Combined uncertainty: 2.9 (Standard deviation (Sd) [Sample])
Epidemic phase: Mid outbreak
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 22
Maximum age: 82
Sample size: 29
Country: Taiwan,  China
Location: Shin Kong
Wu Ho-Su Memorial Hospital, Taipei
Study period: 28 Mar 03 2003 to 30 Jun 06 2003
Other delay start: Admission to Care/Hospitalisation
Other delay end: Fever resolution
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 6.5
Unit: Days
Value type: Mean
Uncertainty single value: 2.9 (Standard deviation (Sd) [Sample])
Combined uncertainty: 2.9 (Standard deviation (Sd) [Sample])
Epidemic phase: Mid outbreak
Population group: Mixed groups
Sample type: Hospital based
Sample size: 15
Country: Taiwan,  China
Location: Shin Kong
Wu Ho-Su Memorial Hospital, Taipei
Study period: 28 Mar 03 2003 to 30 Jun 06 2003
Other delay start: Admission to Care/Hospitalisation
Other delay end: Other: Diarrhoea onset
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 5.8
Unit: Days
Value type: Mean
Uncertainty single value: 2.8 (Standard deviation (Sd) [Sample])
Combined uncertainty: 2.8 (Standard deviation (Sd) [Sample])
Epidemic phase: Mid outbreak
Population group: Mixed groups
Sample type: Hospital based
Sample size: 25
Country: Taiwan,  China
Location: Shin Kong
Wu Ho-Su Memorial Hospital, Taipei
Study period: 28 Mar 03 2003 to 30 Jun 06 2003
Other delay start: Admission to Care/Hospitalisation
Other delay end: Other: Dyspnoea onset
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 5
Unit: Days
Value type: Mean
Uncertainty type: Range [Sample]
Uncertainty lower value: 1
Uncertainty upper value: 10
Uncertainty single value: 2.4 (Standard deviation (Sd) [Sample])
Combined uncertainty: 1 - 10 (Range [Sample])
Epidemic phase: Mid outbreak
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 22
Maximum age: 82
Sample size: 29
Country: Taiwan,  China
Location: Shin Kong
Wu Ho-Su Memorial Hospital, Taipei
Study period: 28 Mar 03 2003 to 30 Jun 06 2003
Other delay start: Symptom Onset/Fever
Other delay end: Initiation of ribavarin treatment
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 9.2
Unit: Days
Value type: Mean
Uncertainty single value: 4 (Standard deviation (Sd) [Sample])
Combined uncertainty: 4 (Standard deviation (Sd) [Sample])
Epidemic phase: Mid outbreak
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 22
Maximum age: 82
Sample size: 29
Country: Taiwan,  China
Location: Shin Kong
Wu Ho-Su Memorial Hospital, Taipei
Study period: 28 Mar 03 2003 to 30 Jun 06 2003
Other delay start: Initiation of ribavirin treatment
Other delay end: End of ribavirin treatment